BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 15179000)

  • 1. Strategies and clinical implications of chimerism diagnostics after allogeneic hematopoietic stem cell transplantation.
    Thiede C; Bornhäuser M; Ehninger G
    Acta Haematol; 2004; 112(1-2):16-23. PubMed ID: 15179000
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Significance of chimerism in hematopoietic stem cell transplantation: new variations on an old theme.
    Khan F; Agarwal A; Agrawal S
    Bone Marrow Transplant; 2004 Jul; 34(1):1-12. PubMed ID: 15156163
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Application of sequential and quantitative monitoring of chimerism in allogeneic hematopoietic stem cell transplantation].
    Tang XW; Wu DP; Zhu ZL; Wang W; Sun AN; Qiu HY; Fu ZZ; Chang WR; Ruan CG
    Zhonghua Xue Ye Xue Za Zhi; 2004 Feb; 25(2):78-81. PubMed ID: 14990044
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quantitative analysis of chimerism after allogeneic stem cell transplantation by real-time polymerase chain reaction with single nucleotide polymorphisms, standard tandem repeats, and Y-chromosome-specific sequences.
    Koldehoff M; Steckel NK; Hlinka M; Beelen DW; Elmaagacli AH
    Am J Hematol; 2006 Oct; 81(10):735-46. PubMed ID: 16838323
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chimerism testing and detection of minimal residual disease after allogeneic hematopoietic transplantation using the bioView (Duet) combined morphological and cytogenetical analysis.
    Shimoni A; Nagler A; Kaplinsky C; Reichart M; Avigdor A; Hardan I; Yeshurun M; Daniely M; Zilberstein Y; Amariglio N; Brok-Simoni F; Rechavi G; Trakhtenbrot L
    Leukemia; 2002 Aug; 16(8):1413-8; discussion 1419-22. PubMed ID: 12145678
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Evaluation of hematopoietic chimerism after allogeneic bone marrow transplantation by modern molecular techniques (STR-PCR and RQ-PCR)--single center].
    Czekalska S; Sacha T; Piatkowska-Jakubas B; Zawada M; Florek I; Cwynar D; Skotnicki AB
    Przegl Lek; 2010; 67(12):1282-91. PubMed ID: 21591354
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Kinetics of plasma-cell chimerism after allogeneic stem cell transplantation by highly sensitive real-time PCR based on sequence polymorphism and its value to quantify minimal residual disease in patients with multiple myeloma.
    Kröger N; Zagrivnaja M; Schwartz S; Badbaran A; Zabelina T; Lioznov M; Ayuk F; Zander A; Fehse B
    Exp Hematol; 2006 May; 34(5):688-94. PubMed ID: 16647575
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Clinical significance of formation and conversion of hematopoietic mixed chimerism in nonmyeloablative allogeneic stem cell transplantation].
    Ai HS; Yu CL; Wang DH; Guo M; Qiao JH; Shi BF; Sun WJ; Zhang S; Sun QY; Yao B
    Zhonghua Yi Xue Za Zhi; 2003 Feb; 83(3):208-11. PubMed ID: 12812663
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of mixed hematopoietic chimerism in pediatric patients with leukemia after allogeneic stem cell transplantation by quantitative PCR analysis of variable number of tandem repeat and testis determination gene.
    Wang LJ; Chou P; Gonzalez-Ryan L; Huang W; Haut PR; Kletzel M
    Bone Marrow Transplant; 2002 Jan; 29(1):51-6. PubMed ID: 11840144
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The clinical significance of interphase fluorescence in situ hybridization monitoring chimeric status after sex-mismatched allogeneic hematopoietic stem cell transplantation for leukemia].
    Liu Q; Song L; Zhang Y; Wei Y; Xu D; Sun J; Liu X; Xu B; Meng F; Zhou S
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2005 Apr; 22(2):212-5. PubMed ID: 15793790
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Detection of relapse by sequential monitoring of chimerism in circulating CD34+ cells.
    Thiede Ch; Lutterbeck K; Oelschlägel U; Kiehl M; Steudel Ch; Platzbecker U; Brendel C; Fauser AA; Neubauer A; Ehninger G; Bornhäuser M
    Ann Hematol; 2002; 81 Suppl 2():S27-8. PubMed ID: 12611065
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Quantitative assessment of hematopoietic chimerism by quantitative real-time polymerase chain reaction of sequence polymorphism systems after hematopoietic stem cell transplantation.
    Qin XY; Li GX; Qin YZ; Wang Y; Wang FR; Liu DH; Xu LP; Chen H; Han W; Wang JZ; Zhang XH; Li JL; Li LD; Liu KY; Huang XJ
    Chin Med J (Engl); 2011 Aug; 124(15):2301-8. PubMed ID: 22029079
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chimerism analysis following hematopoietic stem cell transplantation.
    Murphy KM
    Methods Mol Biol; 2013; 999():137-49. PubMed ID: 23666695
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Real-time PCR for monitoring minimal residual disease and chimerism in patients after allogeneic transplantation.
    Elmaagacli AH
    Int J Hematol; 2002 Aug; 76 Suppl 2():204-5. PubMed ID: 12430926
    [TBL] [Abstract][Full Text] [Related]  

  • 15. FISH detection of chimerism in pediatric hematopoietic stem cell transplantation.
    Aydin F; Oguz F; Onal AE; Bilgen H; Oguz R; Anak S; Carin M; Gedikoglu G
    Int J Lab Hematol; 2007 Jun; 29(3):208-14. PubMed ID: 17474899
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development of an algorithm of satellite markers for monitoring chimerism status in post-allogeneic haematopoietic stem cell transplantation patients.
    Choong SS; Rosmanizam S; Ibrahim K; Gan GG; Ariffin H
    Int J Lab Hematol; 2011 Apr; 33(2):182-6. PubMed ID: 20868447
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Detectable minimal residual disease before allogeneic hematopoietic stem cell transplantation predicts extremely poor prognosis in children with acute lymphoblastic leukemia.
    Sramkova L; Muzikova K; Fronkova E; Krejci O; Sedlacek P; Formankova R; Mejstrikova E; Stary J; Trka J
    Pediatr Blood Cancer; 2007 Jan; 48(1):93-100. PubMed ID: 16521130
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rapid establishment of long-term culture-initiating cells of donor origin after nonmyeloablative allogeneic hematopoietic stem-cell transplantation, and significant prognostic impact of donor T-cell chimerism on stable engraftment and progression-free survival.
    Keil F; Prinz E; Moser K; Mannhalter C; Kalhs P; Worel N; Rabitsch W; Schulenburg A; Mitterbauer M; Greinix H
    Transplantation; 2003 Jul; 76(1):230-6. PubMed ID: 12865815
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Monitoring of donor chimerism in sorted CD34+ peripheral blood cells allows the sensitive detection of imminent relapse after allogeneic stem cell transplantation.
    Bornhäuser M; Oelschlaegel U; Platzbecker U; Bug G; Lutterbeck K; Kiehl MG; Schetelig J; Kiani A; Illmer T; Schaich M; Theuser C; Mohr B; Brendel C; Fauser AA; Klein S; Martin H; Ehninger G; Thiede C
    Haematologica; 2009 Nov; 94(11):1613-7. PubMed ID: 19880783
    [TBL] [Abstract][Full Text] [Related]  

  • 20. X chromosome methylation-based chimerism assay for sex-mismatched hematopoietic stem cell transplantation.
    Yamane A; Karasawa M; Maehara T; Tsukamoto N; Nojima Y
    Bone Marrow Transplant; 2001 Nov; 28(10):969-73. PubMed ID: 11753553
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.